China SXT Pharmaceuticals (SXTC) Market Capitalization (2026)
China SXT Pharmaceuticals (SXTC) posted Market Capitalization of $22046.6 for Q1 2026.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Market Capitalization (2026) Analysis & Trends
China SXT Pharmaceuticals has reported Market Capitalization for 1 years, with the latest figure at $22046.6 in Q1 2026.
- On a quarterly basis, Market Capitalization changed N/A year-over-year to $22046.6 in Q1 2026; TTM through Mar 2026 was $22046.6, a N/A change from a year earlier, with the FY2026 full-year figure at $22046.6, changed N/A from the prior year.
- Market Capitalization was $22046.6 for Q1 2026 at China SXT Pharmaceuticals.
- The five-year high for Market Capitalization was $22046.6 in Q1 2026, with the low at $22046.6 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn |
| 10 | China SXT Pharmaceuticals | 18,436.32 | -28.16 Mn | - |